CoChat

Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity

Gloor, Yvonne, Schvartz, Domitille, F.Samer, Caroline · 2019 · Expert Opinion on Drug Metabolism & Toxicology

The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.

Abstract

Introduction: Although the hepatotoxicity of acetaminophen is a well-known problem, the search for reliable biomarker of toxicity is still a current issue as clinical tools are missing to assess patients intoxicated following chronic use, sequential ingestion, use of modified release formulations or in case of delayed arrival to hospital. The need for new specific and robust biomarkers for acetaminophen toxicity has prompted many studies exploring the use of blood levels of acetaminophen derivatives, mitochondrial damage markers, liver cell apoptosis and/or necrosis markers and circulating microRNAs.Areas covered: In this review, we present a concise overview of the most promising biomarkers currently under evaluation including descriptions of their properties with respect to exposure type, APAP specificity, and potential clinical application. In addition, we illustrate the power of new technologies for biomarker research and describe their current application to the field of acetaminophen-induced hepatotoxicity.Expert opinion: Recently the use of extracellular vesicles isolation in combination with omics techniques has opened a new perspective to the field of biomarker research. However, the potential of those new technologies for the prediction and monitoring of hepatic diseases and acetaminophen toxicity has not yet been fully taken into consideration.

Overview

Integrity signals

Registry

Crossref · 10.1080/17425255.2019.1642323

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 127 references

Research works printed but not linked: 7

  1. Bacle A, 2019, Eur J Clin Pharmacol, 10
  2. Brok J, 2006, Cochrane Database Syst Rev, 2, CD003328
  3. Lindena J, 1986, J Clin Chem Clin Biochem, 24, 35
  4. Wong A, 2017, Clin Toxicol (Phila), 27, 1
  5. Dear JW, 2017, Lancet Gastroenterol Hepatol
  6. Yu D, 2017, Arch Toxicol
  7. Safaei A, 2016, Gastroenterol Hepatol Bed Bench, 9, 158

Cited by

See all 18

Metadata

Authors
Gloor, Y., Schvartz, D., & F.Samer, C.
Affiliations
  • University of Geneva (CH)
  • Division of clinical pharmacology and toxicology, Geneva University Hospital, Geneva, Switzerland
Corresponding author
Gloor, Yvonne
Venue
Expert Opinion on Drug Metabolism & Toxicology
Published
2019-07-15
Volume
15
Issue
8
Pages
659-669
ISSN
  • 1742-5255 (ISSN-L)
  • 1744-7607
OpenAlex
W2958934539
Cited by
18
References
127
Citations by year
2025: 2 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 1
FWCI
0.44
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
paracetamol, hepatotoxicity, biomarkers, apoptosis, necrosis, circulating microRNAs, extracellular vesicles, omics, drug-induced liver injury, modified-release formulation
MeSH terms
Acetaminophen, Animals, Humans, Mitochondria, Research Design, Biomarkers, Apoptosis, Analgesics, Non-Narcotic, MicroRNAs, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity. https://app.cochat.ai/papers/10.1080/17425255.2019.1642323
The paper
Gloor, Y., Schvartz, D., & F.Samer, C. (2019). Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2019.1642323

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.